Medical Research News

RSS

Bariatric surgery offers greater long-term health protection for seniors than GLP-1 drugs

Metabolic and bariatric surgery offers significantly greater long-term protection against heart attack, stroke and death than widely-used GLP-1 drugs in older adults with obesity and diabetes, according to new real-world analysis study presented today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.

6 May 2026

Bariatric surgery outperforms GLP-1 medications for obesity disease remission

Metabolic and bariatric surgery delivers significantly greater weight loss and higher rates of obesity-related disease remission than glucagon-like peptide-1 receptor agonists (GLP-1s), according to one of the largest and most comprehensive real-world comparisons of the two treatments.

6 May 2026

Study examines factors associated with co-occurrence of autism and epilepsy in children

Children with epilepsy have a higher risk of also having autism spectrum disorder (ASD). A new study in Developmental Medicine & Child Neurology examined factors associated with the co-occurrence of autism and epilepsy in a large population-based group.

6 May 2026

Targeting a parasite-specific enzyme offers new hope for malaria treatment

Research published in The FEBS Journal may help overcome challenges to the treatment of malaria-a tropical disease caused by infection of red blood cells with Plasmodium parasites, which are transmitted through infected mosquito bites.

6 May 2026

Daily movement is linked to better mood and emotional well-being

Going on walks, going up stairs, working around the home: One meta-study shows how everyday movements are linked to our mood.

6 May 2026

Organic lithium salts may affect many cellular level changes in Alzheimer's disease

Lithium chloride may affect many cellular level changes in Alzheimer's disease, a new study from the University of Eastern Finland (UEF) shows.

6 May 2026

New inhibitor design provides a blueprint for effective malaria treatments

Researchers from the Universities of Bath and Leeds (UK) have made a significant advance in the fight against malaria by uncovering a promising new potential target for drug discovery.

6 May 2026

At-home blood and brain tests could identify dementia risk earlier

A finger prick blood test combined with online brain testing - all done from home - could one day effectively identify people's risk of developing dementia, according to a new study.

6 May 2026

USF researchers develop AI framework to predict immune system responses

Artificial intelligence is increasingly being used to help scientists accelerate drug discovery and search for new treatments.

6 May 2026

Six genes found to connect pancreatic cancer with metabolic dysfunction

New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain why people with metabolic disease often face poorer cancer outcomes and pointing to future ways to predict recurrence and develop more targeted treatments.

6 May 2026

4basebio announces lease of an innovation hub and manufacturing facility in Cambridge, UK

4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces a significant expansion into a new innovation hub and manufacturing facility in Cambridge, UK, supporting growing demand for research and high-quality grade manufacturing of synthetic DNA for gene and cell therapies, mRNA vaccines, genome editing, or DNA vaccines.

From 4basebio PLC 6 May 2026

Chronic sunlight exposure disrupts body clocks in skin

Years of chronic exposure of human skin to sunlight strongly disrupts its body‑clock rhythm, according to a pioneering study led by University of Manchester, No7 Beauty Company, a member of The Boots Group, and University of Pennsylvania scientists.

6 May 2026

Popular GLP-1 drugs significantly reduce major cardiovascular events,

Researchers evaluate the long-term cardiovascular safety and efficacy of GLP-1RAs in high-risk populations.

6 May 2026

H5N1 spreads through multiple routes on infected dairy farms

The H5N1 strain of highly pathogenic avian influenza H5N1 has been detected in over 700 herds of dairy cows in California, the largest dairy-producing state in the U.S.

5 May 2026

Human telomerase shows limited function across different animal species

A new research paper was published in Volume 18 of Aging-US on April 13, 2026, titled "Cross species activity of TERT human telomerase component."

5 May 2026

Genetic background shapes outcomes in chromosome 16 deletion disorders

Individuals that share the same deletion of a portion of chromosome 16 are at risk of developing neurodevelopmental disorders, but some experience severe intellectual disability or developmental delay, while others may only exhibit milder psychiatric features like depression or anxiety.

5 May 2026

Cruise ship-linked hantavirus cases highlight zoonotic infection risks

The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, collaboration, and pandemic preparedness, is closely monitoring reports of a hantavirus cluster linked to a cruise ship traveling in the Atlantic, which has resulted in multiple severe cases and fatalities.

5 May 2026

Muscle fat levels on MRI linked to cardiometabolic risk

Using a deep learning model to analyze the composition of large muscles on MRI, German researchers found that the proportions of intermuscular fat and lean muscle mass were associated with high blood pressure and unhealthy lipid and blood sugar levels.

5 May 2026

Single psilocybin dose linked to lasting brain and mood changes

Researchers at UC San Francisco and Imperial College London have shown that a single dose of psilocybin, the psychedelic compound found in magic mushrooms, causes likely anatomical brain changes that last for up to a month after the experience.

5 May 2026

Groundbreaking study explores prenatal drug therapy for osteogenesis imperfecta

Shriners Children's St. Louis is proud to announce that one of its lead researchers, Dr. Arin Oestreich, has been awarded a $3.1 million R01 grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

5 May 2026